Employee Benefit Plans (Tables)

6 Months Ended

Dec. 31, 2019

Share Based Compensation [Abstract]

Shares Reserved for Issuance

The Company had reserved for issuance for the periods noted (in thousands):

	December 31, 2019		June 30, 2019
2013 Equity Incentive Plan shares available for grant		10,435		8,462
Employee stock options and awards outstanding		13,541		10,455
2014 Employee Stock Purchase Plan		8,862		10,085
Total shares reserved for issuance		32,838		29,002

Schedule of Recognized Share-based Compensation Expense

Share-based compensation expense

Share-based compensation expense recognized in the condensed consolidated financial statements by line item caption is as follows (in thousands):

	Three Months Ended				Six Months Ended
	December 31, 2019		December 31, 2018		December 31, 2019		December 31, 2018
Cost of product revenue	$	402	$	217	$	652	$	395
Cost of service revenue		505		677		852		1,022
Research and development		3,260		2,797		5,695		5,139
Sales and marketing		3,511		2,983		7,230		5,342
General and administrative		2,801		2,026		4,884		3,627
Integration costs		479		—		479		—
Total share-based compensation expense	$	10,958	$	8,700	$	19,792	$	15,525

Summary of Stock Award Activity

The following table summarizes stock award activity for the six months ended December 31, 2019 (in thousands, except grant date fair value):

	Number of Shares			Weighted- Average Grant Date Fair Value		Aggregate Fair Market Value
Non-vested stock awards outstanding at June 30, 2019		7,736		$	7.67
Granted		6,017			6.86
Released		(2,474	)		7.08
Cancelled		(890	)		7.08
Non-vested stock awards outstanding at December 31, 2019		10,389		$	7.39	$	76,570
Vested and expected to vest at December 31, 2019		9,729		$	7.30	$	71,705

Summary of Stock Option Activity

The following table summarizes stock option activity for the six months ended December 31, 2019 (in thousands, except per share and contractual term):

	Number of Shares			Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Term (years)		Aggregate Intrinsic Value
Options outstanding at June 30, 2019		2,719		$	4.61		3.26	$	5,070
Granted		637			6.70
Exercised		(181	)		4.55
Cancelled		(23	)		4.75
Options outstanding at December 31, 2019		3,152		$	5.03		3.66	$	7,374
Vested and expected to vest at December 31, 2019		3,152		$	5.03		3.66	$	7,374
Exercisable at December 31, 2019		1,735		$	3.80		1.65	$	6,194

Schedule of Fair Value Assumptions for Stock Options and Employee Stock Purchase Plan Awards

The following assumptions were used to calculate the fair value of shares granted under the ESPP during the following periods:

	Employee Stock Purchase Plan
	Six Months Ended
	December 31, 2019			December 31, 2018
Expected life	0.5 years			0.5 years
Risk-free interest rate		1.85	%		2.20	%
Volatility		43	%		63	%
Dividend yield		—	%		—	%